Company Overview
About Examedi
Examedi is a Santiago, Chile-based digital healthcare marketplace — backed by Y Combinator with $14.9 million in revenue in 2024, having received an M&A offer in April 2025 — connecting patients across Latin America with on-demand healthcare services including lab testing at home, telemedicine consultations, home nursing visits, and specialist appointments through a marketplace model that coordinates healthcare workers, labs, and facilities. Founded in 2021 by Andres Kemeny and Juan Pablo Zepeda, Examedi serves patients, employers, health plans, and healthcare facilities throughout Chile, Mexico, Colombia, and broader Latin America as a healthcare access intermediary.
Business Model & Competitive Advantage
Examedi's platform addresses Latin America's fragmented healthcare access problem: in most LatAm cities, patients navigate between public hospital systems (long waits, limited access), private clinics (expensive, disconnected), and independent lab facilities to obtain the full care pathway — a specialist referral, lab testing, imaging, and follow-up. Examedi's marketplace aggregates these touchpoints: patients book home lab visits (a phlebotomist comes to draw blood and process samples at a local lab), telemedicine consultations for common conditions, and in-person specialist appointments with same-day or next-day availability, creating a unified care coordination experience. The employer health benefit integration (corporate wellness plans that include Examedi access) provides B2B channel growth alongside B2C.
Competitive Landscape 2025–2026
In 2025, Examedi competes in the Latin American health tech marketplace market with DoctorAhora (telemedicine, Chile/LatAm), Doctolib (Europe-origin, LatAm expansion), and Sami (Brazil health plan, YC), and Doctor en Casa (home medical visit, Chile) for healthcare access intermediary positioning. LatAm healthcare technology has attracted significant venture investment as growing middle classes demand private healthcare access at more accessible prices than existing private clinic networks provide. The April 2025 M&A offer signals strategic interest from health plans, pharmacy chains, or regional healthcare consolidators seeking digital distribution capability. Y Combinator's backing positioned Examedi in the global health tech investment community. The 2025 strategy focuses on enterprise health benefit contracts (B2B employer channels), expanding telemedicine to the chronic condition management use case, and building the laboratory results intelligence layer.
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
Examedi is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Not So Random Others
Yoneda Labs
Yoneda Labs is a San Francisco-based AI company applying foundation models to automate chemical reaction optimization for drug discovery and pharmaceutical process development — providing chemists wit
Decoda Health
Decoda Health is a San Francisco-based AI healthcare administration platform — backed by Y Combinator (S23) with $4.5 million raised from YC, Amino Capital, Bossa Nova Ventures, Cadenza Ventures, Grap
Fortuna Health
Fortuna Health is a New York City-based healthcare technology company — backed by Y Combinator with $22 million in total funding including an $18 million Series A in July 2025 led by Andreessen Horowi
Brisk
Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione
Altria
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s
AbbVie
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Sp
Compare Examedi with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Examedi? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Examedi Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Examedi vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →